V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16627121 | 330006858 | ECL02 | 2200 | X729 | 1 | 2016-07-12 | TOPOTECAN | 330005418 | 330007942 | 330006860 |
| 16627122 | 330006858 | ED301 | 1650 | X729 | 1 | 2016-07-12 | CYCLOPHOSPHAMIDE | 330005418 | 330007942 | 330006860 |
| 16627123 | 330006858 | EEI00 | 200 | null | 1 | 2016-07-12 | IFOSFAMIDE | 330005418 | 330007942 | 330006860 |
| 16627124 | 330006858 | EUZ | 100 | X721 | 1 | 2016-07-12 | VINCRISTINE | 330005418 | 330007942 | 330006860 |
| 16627125 | 330006859 | ERA20 | 2 | null | 1 | 2018-07-31 | CYCLOPHOSPHAMIDE | 330005420 | 330003622 | 330006861 |
| 16627126 | 330006860 | EKA | 3040 | null | 1 | 2013-08-29 | TOPOTECAN | 330005439 | 330003623 | 330006862 |
| 16627127 | 330006860 | EEI00 | 2800 | null | 1 | 2013-08-29 | MESNA | 330005439 | 330003623 | 330006862 |
| 16627128 | 330006860 | EOF | 150 | null | 2 | 2013-08-30 | DAUNORUBICIN | 330005439 | 330003623 | 330006862 |
| 16627129 | 330006860 | ECL02 | 100 | null | 1 | 2013-08-31 | NOT CHEMO | 330005439 | 330003623 | 330006862 |
| 16627130 | 330006860 | EEI00 | 2 | null | 1 | 2013-08-31 | TRIAL | 330005439 | 330003623 | 330006862 |
| 16627131 | 330006863 | EOI | 4400 | X721 | 2 | 2016-06-23 | MULTIPLE | 330005461 | 330007945 | 330006865 |
| 16627132 | 330006864 | ED301 | 2600 | null | 1 | 2013-07-04 | CETUXIMAB | 330005470 | 330003628 | 330006866 |
| 16627133 | 330006864 | ERS12 | 1000 | X724 | 5 | 2013-07-04 | VINCRISTINE | 330005470 | 330003628 | 330006866 |
| 16627134 | 330006864 | EN710 | 2640 | null | 1 | 2013-07-04 | CYTARABINE | 330005470 | 330003628 | 330006866 |
| 16627135 | 330006864 | E1UZ0 | 100 | null | 1 | 2013-07-05 | CYCLOPHOSPHAMIDE | 330005470 | 330003628 | 330006866 |
| 16627136 | 330006864 | ECL01 | 1200 | null | 2 | 2013-07-06 | TOPOTECAN | 330005470 | 330003628 | 330006866 |
| 16627137 | 330006864 | EEI00 | 20 | N/A | 1 | 2013-07-06 | ETOPOSIDE | 330005470 | 330003628 | 330006866 |
| 16627138 | 330006864 | ERA20 | 150 | X724 | null | 2013-07-06 | CISPLATIN | 330005470 | 330003628 | 330006866 |
| 16627139 | 330006864 | EII | 1000 | X721 | 0 | 2013-07-06 | NOT CHEMO | 330005470 | 330003628 | 330006866 |
| 16627141 | 330006866 | ELW | 1.3 | null | 1 | 2014-04-20 | STEROID | 330005491 | 330003629 | 330006868 |
| 16627142 | 330006867 | EPH | 4240 | null | 0 | 2016-08-31 | RITUXIMAB | 330005499 | 330003630 | 330006869 |
| 16627143 | 330006867 | EEI00 | 300 | X721 | 1 | 2016-08-31 | FLUDARABINE | 330005499 | 330003630 | 330006869 |
| 16627144 | 330006867 | ECL01 | 55 | null | 2 | 2016-09-07 | RITUXIMAB | 330005499 | 330003630 | 330006869 |
| 16627145 | 330006868 | ECL01 | 64 | X724 | 1 | 2017-12-15 | CISPLATIN | 330005499 | 330003630 | 330006870 |
| 16627146 | 330006868 | EE813 | 55 | null | 1 | 2017-12-15 | RITUXIMAB | 330005499 | 330003630 | 330006870 |
| 16627147 | 330006868 | EEI00 | 1760 | X724 | 1 | 2017-12-15 | MULTIPLE | 330005499 | 330003630 | 330006870 |
| 16627148 | 330006870 | EEI00 | 72 | X729 | 1 | 2015-11-07 | ETOPOSIDE | 330005522 | 330003636 | 330006872 |
| 16627149 | 330006870 | EE813 | 0.95 | X724 | 1 | 2015-11-07 | BMS-986016 | 330005522 | 330003636 | 330006872 |
| 16627150 | 330006870 | EEI00 | 3200 | null | 1 | 2015-11-07 | CETUXIMAB | 330005522 | 330003636 | 330006872 |
| 16627151 | 330006870 | EK1PP | 210 | X724 | 1 | 2015-11-07 | IFOSFAMIDE | 330005522 | 330003636 | 330006872 |
| 16627152 | 330006870 | EEI00 | 5500 | X722 | 1 | 2015-11-08 | VINCRISTINE | 330005522 | 330003636 | 330006872 |
| 16627153 | 330006871 | E1UZ0 | 197 | null | 1 | 2013-10-15 | ETOPOSIDE | 330005545 | 330007956 | 330006873 |
| 16627154 | 330006871 | EOF | 1.9 | null | 1 | 2013-10-15 | TOPOTECAN | 330005545 | 330007956 | 330006873 |
| 16627155 | 330006871 | E0N03 | 290 | X721 | 2 | 2013-10-16 | IFOSFAMIDE | 330005545 | 330007956 | 330006873 |
| 16627156 | 330006871 | EEI00 | 180 | null | 1 | 2013-10-17 | DOCETAXEL | 330005545 | 330007956 | 330006873 |
| 16627157 | 330006872 | EK1EN | 22 | null | 1 | 2016-05-17 | AZACITIDINE | 330005548 | 330003638 | 330006874 |
| 16627158 | 330006873 | ECL01 | null | X729 | 1 | 2014-12-10 | IFOSFAMIDE | 330005548 | 330003638 | 330006875 |
| 16627159 | 330006873 | EEI00 | 56 | X728 | 1 | 2014-12-11 | IFOSFAMIDE | 330005548 | 330003638 | 330006875 |
| 16627160 | 330006873 | EJR | 4800 | null | 1 | 2014-12-11 | CYTARABINE | 330005548 | 330003638 | 330006875 |
| 16627161 | 330006874 | EEI00 | 58 | X724 | 1 | 2017-01-12 | STEROID | 330005555 | 330003641 | 330006876 |
| 16627162 | 330006875 | EE813 | 1650 | null | 1 | 2017-12-03 | CETUXIMAB | 330005564 | 330007958 | 330006877 |
| 16627163 | 330006876 | E1UZ0 | 170 | null | 1 | 2017-09-25 | CISPLATIN | 330005564 | 330003643 | 330006878 |
| 16627164 | 330006876 | EOF | 1800 | null | 1 | 2017-10-02 | NOT CHEMO | 330005564 | 330003643 | 330006878 |
| 16627165 | 330006876 | ECL02 | 200 | X292 | 1 | 2017-10-02 | ETOPOSIDE | 330005564 | 330003643 | 330006878 |
| 16627166 | 330006877 | EEI00 | 60 | null | 2 | 2015-05-10 | CETUXIMAB | 330005584 | 330007960 | 330006879 |
| 16627167 | 330006879 | E0N03 | 1680 | X729 | 1 | 2015-01-18 | STEROID | 330005595 | 330003647 | 330006881 |
| 16627168 | 330006882 | EEI00 | 1650 | null | 1 | 2017-09-23 | AVELUMAB | 330005613 | 330012354 | 330006884 |
| 16627169 | 330006882 | EEI00 | 1300 | X721 | 1 | 2017-09-23 | NOT CHEMO | 330005613 | 330012354 | 330006884 |
| 16627170 | 330006883 | EJRNN | 1680 | null | 2 | 2017-05-23 | AVELUMAB | 330005613 | 330012354 | 330006885 |
| 16627171 | 330006883 | EGU08 | 1.1 | X721 | 1 | 2017-05-23 | CETUXIMAB | 330005613 | 330012354 | 330006885 |